Argenx Se (ARGX) Stock Forecast & Price Target

Compare

664 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ARGX Analyst Ratings

Strong Buy

21 Buy

2 Hold

0 Sell

Based on 23 analysts giving stock ratings to

Argenx

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ARGX Stock 12 Month Forecast

Average Price Target

$814.21

▲(6.64% Upside)

Based on 23 Wall Street analysts offering 12 month price targets for Argenx Se in the last 3 months. The average price target is $814.21 with a high forecast of $1,070.00 and a low forecast of $710.00. The average price target represents a 6.64% change from the last price of $763.52.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"516":"$516","1071":"$1,071","654.75":"$654.8","793.5":"$793.5","932.25":"$932.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1070,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.07K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":814.21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$814.21</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":710,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$710.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[516,654.75,793.5,932.25,1071],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,706.41,734.3784615384615,762.3469230769231,790.3153846153846,818.2838461538461,846.2523076923077,874.2207692307692,902.1892307692308,930.1576923076923,958.1261538461538,986.0946153846154,1014.0630769230769,1042.0315384615385,{"y":1070,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,706.41,714.7023076923076,722.9946153846154,731.286923076923,739.5792307692308,747.8715384615384,756.1638461538462,764.4561538461538,772.7484615384616,781.0407692307692,789.333076923077,797.6253846153846,805.9176923076924,{"y":814.21,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,706.41,706.6861538461538,706.9623076923077,707.2384615384615,707.5146153846154,707.7907692307692,708.0669230769231,708.3430769230769,708.6192307692307,708.8953846153846,709.1715384615385,709.4476923076923,709.7238461538461,{"y":710,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":517.32,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":547.28,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":595.58,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":617.49,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":615,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":655.13,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":624.67,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":567.09,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":639.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":584.6,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":542.47,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":673.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":706.41,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$1,070

Average Price Target$814.21

Lowest Price Target$710.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Emmanuel Papadakis

Deutsche Bank

―

Hold

―

Downgraded

09/11/25

Argenx downgraded to Hold from Buy at Deutsche BankArgenx downgraded to Hold from Buy at Deutsche Bank

Tazeen Ahmad

Bank of America Securities

$887

Buy

16.17%

Upside

Reiterated

09/09/25

Bank of America Securities Sticks to Its Buy Rating for Argenx Se (ARGX)We maintain our Buy with $887/€757 PO.

Myles Minter

William Blair

―

Buy

―

Reiterated

09/02/25

Argenx: A Promising Growth Opportunity with Strategic Expansion and Diversification Beyond VyvgartWe hosted Karen Massey, chief operating officer, and Beth DelGiacco, vice president of corporate communications and investor relations, of argenx management for investor meetings in Milan, Italy. We remain bullish on the growth trajectory of the Vyvgart franchise in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP) but also the company’s vision for sustainable growth into 2030 and beyond with 5 new molecules in Phase III trials, 10 labeled indications, and over 50,000 patients on argenx therapies within this time frame.

Allison Bratzel

Piper Sandler

$750→$820

Buy

7.40%

Upside

Reiterated

08/26/25

Piper Sandler Keeps Their Buy Rating on Argenx Se (ARGX)

Akash Tewari

Jefferies

$795→$808

Buy

5.83%

Upside

Assigned

08/26/25

Jefferies Remains a Buy on Argenx Se (ARGX)

Leland Gershell

Oppenheimer

$778

Buy

1.90%

Upside

Reiterated

08/26/25

Oppenheimer Reaffirms Their Buy Rating on Argenx Se (ARGX)

Thomas Smith

Leerink Partners

―

Buy

―

Reiterated

08/25/25

Argenx Se's Vyvgart Gains Momentum with Successful Phase 3 Results and Market Expansion PotentialWe continue to highlight ARGX’s strategic trial design and execution, which should further differentiate Vyvgart in an increasingly competitive MG landscape (see our recent MG Primer deep dive HERE and Primer HERE). Looking ahead, ARGX plans to submit an sBLA seeking to expand the Vyvgart label to include all three subtypes of AChR-Ab seronegative MG (MuSK+, LRP4+, triple seronegative) by the end of 2025.

Kenneth Lee

RBC Capital

$850

Buy

11.33%

Upside

Initiated

08/25/25

Argenx initiated with an Outperform at RBC CapitalArgenx initiated with an Outperform at RBC Capital

Alex Thompson CFA

Stifel Nicolaus

$797

Buy

4.38%

Upside

Reiterated

08/18/25

James Gordon

J.P. Morgan

$775→$830

Buy

8.71%

Upside

Reiterated

08/04/25

J.P. Morgan Keeps Their Buy Rating on Argenx Se (ARGX)JPMorgan analyst James Gordon raised the price target on argenx SE (NASDAQ: ARGX) to $830.00 (from $775.00) while maintaining a Overweight rating.

Joon Lee

Truist Financial

―

Buy

―

Reiterated

08/01/25

Truist Financial Sticks to Their Buy Rating for Argenx Se (ARGX)

Yaron Werber

TD Cowen

$761→$800

Buy

4.78%

Upside

Assigned

08/01/25

Argenx's Vyvgart Sales Surpass Expectations, Driving Buy Rating with Promising Pipeline and Market Expansion

Joel Beatty

Robert W. Baird

$680→$788

Buy

3.21%

Upside

Reiterated

08/01/25

Argenx price target raised to $788 from $680 at BairdArgenx price target raised to $788 from $680 at Baird

Derek Archila

Wells Fargo

$741→$756

Buy

-0.98%

Downside

Reiterated

08/01/25

Argenx SE's Strong Q2 Performance and Positive Outlook Reinforce Buy RatingWe believe shares could trade up +10-15% on Vyvgart's 2Q revs of $949MM, particularly as buyside's bull case was $910-$920MM. This should help address investor growth/ pricing concerns—ARGX's growth story is intact.

Douglas Tsao

H.C. Wainwright

$720→$774

Buy

1.37%

Upside

Reiterated

08/01/25

Argenx Se's Strong Market Position and Impressive Financial Performance Drive Buy Rating

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Emmanuel Papadakis

Deutsche Bank

―

Hold

―

Downgraded

09/11/25

Argenx downgraded to Hold from Buy at Deutsche BankArgenx downgraded to Hold from Buy at Deutsche Bank

Tazeen Ahmad

Bank of America Securities

$887

Buy

16.17%

Upside

Reiterated

09/09/25

Bank of America Securities Sticks to Its Buy Rating for Argenx Se (ARGX)We maintain our Buy with $887/€757 PO.

Myles Minter

William Blair

―

Buy

―

Reiterated

09/02/25

Allison Bratzel

Piper Sandler

$750→$820

Buy

7.40%

Upside

Reiterated

08/26/25

Piper Sandler Keeps Their Buy Rating on Argenx Se (ARGX)

Akash Tewari

Jefferies

$795→$808

Buy

5.83%

Upside

Assigned

08/26/25

Jefferies Remains a Buy on Argenx Se (ARGX)

Leland Gershell

Oppenheimer

$778

Buy

1.90%

Upside

Reiterated

08/26/25

Oppenheimer Reaffirms Their Buy Rating on Argenx Se (ARGX)

Thomas Smith

Leerink Partners

―

Buy

―

Reiterated

08/25/25

Kenneth Lee

RBC Capital

$850

Buy

11.33%

Upside

Initiated

08/25/25

Argenx initiated with an Outperform at RBC CapitalArgenx initiated with an Outperform at RBC Capital

Alex Thompson CFA

Stifel Nicolaus

$797

Buy

4.38%

Upside

Reiterated

08/18/25

James Gordon

J.P. Morgan

$775→$830

Buy

8.71%

Upside

Reiterated

08/04/25

Joon Lee

Truist Financial

―

Buy

―

Reiterated

08/01/25

Truist Financial Sticks to Their Buy Rating for Argenx Se (ARGX)

Yaron Werber

TD Cowen

$761→$800

Buy

4.78%

Upside

Assigned

08/01/25

Argenx's Vyvgart Sales Surpass Expectations, Driving Buy Rating with Promising Pipeline and Market Expansion

Joel Beatty

Robert W. Baird

$680→$788

Buy

3.21%

Upside

Reiterated

08/01/25

Argenx price target raised to $788 from $680 at BairdArgenx price target raised to $788 from $680 at Baird

Derek Archila

Wells Fargo

$741→$756

Buy

-0.98%

Downside

Reiterated

08/01/25

Douglas Tsao

H.C. Wainwright

$720→$774

Buy

1.37%

Upside

Reiterated

08/01/25

Argenx Se's Strong Market Position and Impressive Financial Performance Drive Buy Rating

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Argenx Se

1 Month

xxx

Success Rate

16/23 ratings generated profit

Average Return

+4.90%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 69.57% of your transactions generating a profit, with an average return of +4.90% per trade.

3 Months

xxx

Success Rate

23/32 ratings generated profit

Average Return

+16.34%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 71.88% of your transactions generating a profit, with an average return of +16.34% per trade.

1 Year

Allison BratzelPiper Sandler

Success Rate

22/23 ratings generated profit

Average Return

+29.63%

reiterated a buy rating 18 days ago

Copying Allison Bratzel's trades and holding each position for 1 Year would result in 95.65% of your transactions generating a profit, with an average return of +29.63% per trade.

2 Years

xxx

Success Rate

32/32 ratings generated profit

Average Return

+85.94%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +85.94% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ARGX Analyst Recommendation Trends

Rating

May 25

Jun 25

Jul 25

Aug 25

Sep 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ARGX has received 39 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ARGX average Analyst price target in the past 3 months is 814.21.

Each month's total comprises the sum of three months' worth of ratings.

ARGX Financial Forecast

ARGX Earnings Forecast

Next quarter’s earnings estimate for ARGX is $4.52 with a range of $3.30 to $6.49. The previous quarter’s EPS was $3.74. ARGX beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.16% of the time in the same period. In the last calendar year ARGX has Preformed in-line its overall industry.

ARGX Sales Forecast

Next quarter’s sales forecast for ARGX is $1.07B with a range of $976.64M to $1.15B. The previous quarter’s sales results were $1.75B. ARGX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.17% of the time in the same period. In the last calendar year ARGX has Preformed in-line its overall industry.

ARGX Stock Forecast FAQ

What is ARGX’s average 12-month price target, according to analysts?

Based on analyst ratings, Argenx Se’s 12-month average price target is 814.21.

What is ARGX’s upside potential, based on the analysts’ average price target?

Argenx Se has 6.64% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ARGX a Buy, Sell or Hold?

Argenx Se has a consensus rating of Strong Buy which is based on 21 buy ratings, 2 hold ratings and 0 sell ratings.

What is Argenx Se’s price target?

The average price target for Argenx Se is 814.21. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1,070.00 ,the lowest forecast is $710.00. The average price target represents 6.64% Increase from the current price of $763.52.

What do analysts say about Argenx Se?

Argenx Se’s analyst rating consensus is a Strong Buy. This is based on the ratings of 23 Wall Streets Analysts.

How can I buy shares of ARGX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Argenx Se (ARGX) Stock Forecast & Price Target

ARGX Analyst Ratings

ARGX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Argenx Se

ARGX Analyst Recommendation Trends

ARGX Financial Forecast

ARGX Earnings Forecast

ARGX Sales Forecast

ARGX Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts